Donor-derived malignancy in organ transplant recipients.
Sheil
A G
AG
Departments of Surgery, Royal Prince Alfred Hospital and the University of Sydney, Sydney, New South Wales, Australia.
D002292:Carcinoma, Renal Cell / Q000209:etiology / Q000401:mortality; D002822:Choriocarcinoma / Q000209:etiology / Q000401:mortality; D003951:Diagnostic Errors; D006801:Humans; D007165:Immunosuppression Therapy; D007680:Kidney Neoplasms / Q000209:etiology / Q000401:mortality; D016030:Kidney Transplantation / Q000009:adverse effects; D008545:Melanoma / Q000209:etiology / Q000401:mortality; D009369:Neoplasms / Q000209:etiology* / Q000401:mortality / Q000628:therapy; D009820:Ohio / Q000453:epidemiology; D016377:Organ Transplantation / Q000009:adverse effects*; D012042:Registries / Q000706:statistics & numerical data